By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oncoscience AG 

Hafenstra├če 32

Wedel    22880  Germany
Phone: 49-4103-180-880 Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
YM BioSciences (YM.TO)' Subsidary Resolves Proposed Arbitration with Oncoscience AG 6/29/2009 10:32:14 AM
YM BioSciences (YM.TO) Subsidary Notifies Oncoscience AG of Intention to Submit Issues for Arbitration 11/17/2008 10:42:31 AM
YM BioSciences (YM.TO)', European Partner, Oncoscience AG, Announces Initiation Of Advanced Nimotuzumab Trials In Adult Glioma And Pancreatic Cancer 8/21/2007 7:37:40 AM
Oncoscience AG Announces Completion of Patient Enrollment in Phase 3 Trial 8/15/2007 8:07:46 AM
YM BioSciences (YM.TO)' Partner, Oncoscience AG, Commences Patient Treatment In Phase III Trial In Germany With Nimotuzumab 4/27/2006 10:21:37 AM
YM BioSciences (YM.TO)' Partner, Oncoscience AG, Cleared For Phase III Trial In Germany With Nimotuzumab 3/28/2006 10:27:00 AM
YM BioSciences' (YM.TO) TheraCIM Receives Investigator Sponsored IND From FDA10/19/2005 5:13:02 PM
YM BioSciences (YM.TO) Partner, Oncoscience AG, Reports Update Of Pediatric Brain Cancer Data10/19/2005 5:12:58 PM
YM BioSciences (YM.TO) And Oncoscience AG Report Response Rate Of 35.3% In Pediatric Glioma10/19/2005 5:12:52 PM
YM BioSciences (YM.TO) And Oncoscience AG Achieve Clinical Milestone10/19/2005 5:12:32 PM
12
//-->